Singh Sanminder, Young Paulina, Armstrong April W
University of California, Davis School of Medicine, Sacramento, California, United States of America.
Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
PLoS One. 2017 Jul 18;12(7):e0181039. doi: 10.1371/journal.pone.0181039. eCollection 2017.
The relationship between psoriasis and metabolic syndrome is not well understood. Though multiple epidemiologic studies have suggested a link between psoriasis and metabolic syndrome, there is a lack of a comprehensive meta-analysis synthesizing the results of all available observational studies to date. In this meta-analysis, we examined global data on the relationship between psoriasis and odds of metabolic syndrome by searching for studies published between 1946-2016. Specifically, we analyzed the results from 35 observational studies from 20 countries with 1,450,188 total participants, of which 46,714 were psoriasis patients. The pooled odds ratio based on random effects analysis was 2.14 (95% CI 1.84-2.48). Publication bias was present, as evidenced by an Egger test and graphical visualization through a funnel plot (p = 0.001). Based on this comprehensive meta-analysis, psoriasis patients have higher odds of having metabolic syndrome when compared with the general population.
J Am Acad Dermatol. 2013-1-27
Endocr Metab Immune Disord Drug Targets. 2020
Actas Dermosifiliogr. 2017-5
J Am Acad Dermatol. 2017-10
J Eur Acad Dermatol Venereol. 2022-11
G Ital Dermatol Venereol. 2016-12
Clin Exp Dermatol. 2017-3
J Diabetes Investig. 2017-5-24
Dermatol Pract Concept. 2025-7-31
Nutr Metab (Lond). 2025-5-6
J Inflamm Res. 2025-1-10
Arterioscler Thromb Vasc Biol. 2024-12
Curr Health Sci J. 2024
Diagnostics (Basel). 2024-8-14
Clin Cosmet Investig Dermatol. 2023-8-23
Psoriasis (Auckl). 2015-11-2
Vojnosanit Pregl. 2016-11
G Ital Dermatol Venereol. 2016-12
J Clin Invest. 2016-7-1